Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Novonesis (Novozymes) B

Ylin-
Alin-
Vaihto-
2026 Q1 -tulosraportti
95 päivää sitten
4,25 DKK/osake
Viimeisin osinko
1,52%Tuotto/v

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
5.5.
2025 Q4 -tulosraportti
25.2.
2025 Q3 -tulosraportti
6.11.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
8.5.2025

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 3 päivää sitten
    ·
    Without much experience, I think that the increase can be more stable over a longer period.
  • 4.8.
    ·
    Novonesis-peer upgrades with reference to tailwind for biofuel Close today at 12:35 ∙ MarketWire Premium Novonesis-peer Archer-Daniels-Midland, ADM, upgrades its earnings expectations for the second time this year, as the crop trader increasingly looks to biofuels as a way to drive growth. This is well received in Tuesday's US premarket, where the stock is sent up by 3.9 pct. to 81.11 dollar. Revenue landed at 22.7 bn. dollar in the second quarter, where analyst consensus collected by Bloomberg News expected 22.05 bn. dollar. Most of the revenue is generated in the agricultural services and oilseeds division, which generated 17.9 bn. dollar in the second quarter. Here, operating earnings rose by 129 pct. to 867 mio. dollar against an expected increase to 788.3 mio. dollar. Earnings per share also positively surprise by reaching 1.84 dollar against an expected 1.49 dollar. The improvement comes at a time when many countries want to blend ever larger quantities of biofuels into gasoline and diesel, while wars disrupt the flow of crude oil from the Middle East and grain supplies from the Black Sea region. ADM is one of the world's largest processing companies for soybeans and corn, which are key raw materials for plant- and animal-based fuels, whose prices often follow the development of crude oil. For 2026, expectations for adjusted earnings per share are upgraded to 5.15-5.60 dollar from 4.15-4.70 dollar, which is significantly above analyst consensus of 4.82 dollar. The updated forecast reflects an expected year-over-year improvement in earnings in ADM's crushing and ethanol businesses, as the company expects to continue to capitalize on the favorable margin environment through disciplined execution, ADM writes in the report and continues: This margin environment is primarily due to the finally set Renewable Volume Obligations (RVO) for 2026 and 2027 under the US Renewable Fuel Standard, which was established in March 2026, supported by global trade dynamics and high energy prices. In addition, the development in Nutrition continues to improve.
    4.8.
    ·
    Interesting. I wonder if the Novonesis share can rise 50 øre on that news?
  • 30.7.
    ·
    Novonesis competitor with double-digit increase after better-than-expected sales Close today at 10:59 ∙ MarketWire The share in DSM-Firmenich, which like Danish Novonesis operates in the ingredient market, gained momentum on Thursday, after the Dutch-Swiss company's sales performed better than expected in the second quarter. Bloomberg News reports this. JPMorgan analyst Chetan Udeshi notes that "second-quarter organic sales growth of 6 pct. exceeds expectations in all divisions, led by 7 pct. growth in the perfume and beauty division and double-digit increases in exclusive and consumer perfumes". Overall, second-quarter sales amounted to 2.39 billion euro. The DSM share rises by 11.7 pct. to 93.16 euro.
    30.7.
    ·
    Just added a little bit extra now :)
  • 30.7. · Muokattu
    ·
    Must admit that I look forward to the financial report 20.8. I would say that there could well be an upward adjustment...after which we could well climb up towards 500....In my eyes, it is a rock-solid stock. What does the panel think?
    3.8.
    ·
    I am considering selling it. As far as I can see, it is not performing very well. It is definitely not a stock I should have more of.
  • 23.7.
    ·
    Their peer has simply lost market share to Novonesis, which is simultaneously expanding in Asia.
    24.7.
    ·
    Yes, it seems absurd that Novonesis should fall 3.4% on the news that a Swiss competitor has performed less well. But ok, it was generally a red day yesterday, so that probably also left its mark on the stock. I will use the dip to add a bit, and believe that it will recover some of what was lost today.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q1 -tulosraportti
95 päivää sitten
4,25 DKK/osake
Viimeisin osinko
1,52%Tuotto/v

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 3 päivää sitten
    ·
    Without much experience, I think that the increase can be more stable over a longer period.
  • 4.8.
    ·
    Novonesis-peer upgrades with reference to tailwind for biofuel Close today at 12:35 ∙ MarketWire Premium Novonesis-peer Archer-Daniels-Midland, ADM, upgrades its earnings expectations for the second time this year, as the crop trader increasingly looks to biofuels as a way to drive growth. This is well received in Tuesday's US premarket, where the stock is sent up by 3.9 pct. to 81.11 dollar. Revenue landed at 22.7 bn. dollar in the second quarter, where analyst consensus collected by Bloomberg News expected 22.05 bn. dollar. Most of the revenue is generated in the agricultural services and oilseeds division, which generated 17.9 bn. dollar in the second quarter. Here, operating earnings rose by 129 pct. to 867 mio. dollar against an expected increase to 788.3 mio. dollar. Earnings per share also positively surprise by reaching 1.84 dollar against an expected 1.49 dollar. The improvement comes at a time when many countries want to blend ever larger quantities of biofuels into gasoline and diesel, while wars disrupt the flow of crude oil from the Middle East and grain supplies from the Black Sea region. ADM is one of the world's largest processing companies for soybeans and corn, which are key raw materials for plant- and animal-based fuels, whose prices often follow the development of crude oil. For 2026, expectations for adjusted earnings per share are upgraded to 5.15-5.60 dollar from 4.15-4.70 dollar, which is significantly above analyst consensus of 4.82 dollar. The updated forecast reflects an expected year-over-year improvement in earnings in ADM's crushing and ethanol businesses, as the company expects to continue to capitalize on the favorable margin environment through disciplined execution, ADM writes in the report and continues: This margin environment is primarily due to the finally set Renewable Volume Obligations (RVO) for 2026 and 2027 under the US Renewable Fuel Standard, which was established in March 2026, supported by global trade dynamics and high energy prices. In addition, the development in Nutrition continues to improve.
    4.8.
    ·
    Interesting. I wonder if the Novonesis share can rise 50 øre on that news?
  • 30.7.
    ·
    Novonesis competitor with double-digit increase after better-than-expected sales Close today at 10:59 ∙ MarketWire The share in DSM-Firmenich, which like Danish Novonesis operates in the ingredient market, gained momentum on Thursday, after the Dutch-Swiss company's sales performed better than expected in the second quarter. Bloomberg News reports this. JPMorgan analyst Chetan Udeshi notes that "second-quarter organic sales growth of 6 pct. exceeds expectations in all divisions, led by 7 pct. growth in the perfume and beauty division and double-digit increases in exclusive and consumer perfumes". Overall, second-quarter sales amounted to 2.39 billion euro. The DSM share rises by 11.7 pct. to 93.16 euro.
    30.7.
    ·
    Just added a little bit extra now :)
  • 30.7. · Muokattu
    ·
    Must admit that I look forward to the financial report 20.8. I would say that there could well be an upward adjustment...after which we could well climb up towards 500....In my eyes, it is a rock-solid stock. What does the panel think?
    3.8.
    ·
    I am considering selling it. As far as I can see, it is not performing very well. It is definitely not a stock I should have more of.
  • 23.7.
    ·
    Their peer has simply lost market share to Novonesis, which is simultaneously expanding in Asia.
    24.7.
    ·
    Yes, it seems absurd that Novonesis should fall 3.4% on the news that a Swiss competitor has performed less well. But ok, it was generally a red day yesterday, so that probably also left its mark on the stock. I will use the dip to add a bit, and believe that it will recover some of what was lost today.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
5.5.
2025 Q4 -tulosraportti
25.2.
2025 Q3 -tulosraportti
6.11.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
8.5.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q1 -tulosraportti
95 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
20.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
5.5.
2025 Q4 -tulosraportti
25.2.
2025 Q3 -tulosraportti
6.11.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
8.5.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

4,25 DKK/osake
Viimeisin osinko
1,52%Tuotto/v

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 3 päivää sitten
    ·
    Without much experience, I think that the increase can be more stable over a longer period.
  • 4.8.
    ·
    Novonesis-peer upgrades with reference to tailwind for biofuel Close today at 12:35 ∙ MarketWire Premium Novonesis-peer Archer-Daniels-Midland, ADM, upgrades its earnings expectations for the second time this year, as the crop trader increasingly looks to biofuels as a way to drive growth. This is well received in Tuesday's US premarket, where the stock is sent up by 3.9 pct. to 81.11 dollar. Revenue landed at 22.7 bn. dollar in the second quarter, where analyst consensus collected by Bloomberg News expected 22.05 bn. dollar. Most of the revenue is generated in the agricultural services and oilseeds division, which generated 17.9 bn. dollar in the second quarter. Here, operating earnings rose by 129 pct. to 867 mio. dollar against an expected increase to 788.3 mio. dollar. Earnings per share also positively surprise by reaching 1.84 dollar against an expected 1.49 dollar. The improvement comes at a time when many countries want to blend ever larger quantities of biofuels into gasoline and diesel, while wars disrupt the flow of crude oil from the Middle East and grain supplies from the Black Sea region. ADM is one of the world's largest processing companies for soybeans and corn, which are key raw materials for plant- and animal-based fuels, whose prices often follow the development of crude oil. For 2026, expectations for adjusted earnings per share are upgraded to 5.15-5.60 dollar from 4.15-4.70 dollar, which is significantly above analyst consensus of 4.82 dollar. The updated forecast reflects an expected year-over-year improvement in earnings in ADM's crushing and ethanol businesses, as the company expects to continue to capitalize on the favorable margin environment through disciplined execution, ADM writes in the report and continues: This margin environment is primarily due to the finally set Renewable Volume Obligations (RVO) for 2026 and 2027 under the US Renewable Fuel Standard, which was established in March 2026, supported by global trade dynamics and high energy prices. In addition, the development in Nutrition continues to improve.
    4.8.
    ·
    Interesting. I wonder if the Novonesis share can rise 50 øre on that news?
  • 30.7.
    ·
    Novonesis competitor with double-digit increase after better-than-expected sales Close today at 10:59 ∙ MarketWire The share in DSM-Firmenich, which like Danish Novonesis operates in the ingredient market, gained momentum on Thursday, after the Dutch-Swiss company's sales performed better than expected in the second quarter. Bloomberg News reports this. JPMorgan analyst Chetan Udeshi notes that "second-quarter organic sales growth of 6 pct. exceeds expectations in all divisions, led by 7 pct. growth in the perfume and beauty division and double-digit increases in exclusive and consumer perfumes". Overall, second-quarter sales amounted to 2.39 billion euro. The DSM share rises by 11.7 pct. to 93.16 euro.
    30.7.
    ·
    Just added a little bit extra now :)
  • 30.7. · Muokattu
    ·
    Must admit that I look forward to the financial report 20.8. I would say that there could well be an upward adjustment...after which we could well climb up towards 500....In my eyes, it is a rock-solid stock. What does the panel think?
    3.8.
    ·
    I am considering selling it. As far as I can see, it is not performing very well. It is definitely not a stock I should have more of.
  • 23.7.
    ·
    Their peer has simply lost market share to Novonesis, which is simultaneously expanding in Asia.
    24.7.
    ·
    Yes, it seems absurd that Novonesis should fall 3.4% on the news that a Swiss competitor has performed less well. But ok, it was generally a red day yesterday, so that probably also left its mark on the stock. I will use the dip to add a bit, and believe that it will recover some of what was lost today.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Ei dataa

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
----

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt